Aerovate Therapeutics Stock Forecast - Accumulation Distribution
| AVTE Stock | USD 2.32 0.04 1.69% |
Aerovate Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Aerovate Therapeutics stock prices and determine the direction of Aerovate Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Aerovate Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Aerovate |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 29922.55 | 2903.16 |
| Check Aerovate Therapeutics Volatility | Backtest Aerovate Therapeutics | Information Ratio |
Aerovate Therapeutics Trading Date Momentum
| On October 17 2024 Aerovate Therapeutics was traded for 2.32 at the closing time. The top price for the day was 2.37 and the lowest listed price was 2.27 . The trading volume for the day was 68.8 K. The trading history from October 17, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.86% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Aerovate Therapeutics to competition |
Other Forecasting Options for Aerovate Therapeutics
For every potential investor in Aerovate, whether a beginner or expert, Aerovate Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Aerovate Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Aerovate. Basic forecasting techniques help filter out the noise by identifying Aerovate Therapeutics' price trends.Aerovate Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aerovate Therapeutics stock to make a market-neutral strategy. Peer analysis of Aerovate Therapeutics could also be used in its relative valuation, which is a method of valuing Aerovate Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Aerovate Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Aerovate Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Aerovate Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Aerovate Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Aerovate Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aerovate Therapeutics shares will generate the highest return on investment. By undertsting and applying Aerovate Therapeutics stock market strength indicators, traders can identify Aerovate Therapeutics entry and exit signals to maximize returns.
Aerovate Therapeutics Risk Indicators
The analysis of Aerovate Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aerovate Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aerovate stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.37 | |||
| Semi Deviation | 2.47 | |||
| Standard Deviation | 3.08 | |||
| Variance | 9.48 | |||
| Downside Variance | 8.01 | |||
| Semi Variance | 6.1 | |||
| Expected Short fall | (2.91) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| AVAV | AeroVironment | |
| ELVN | Enliven Therapeutics | |
| NFLX | Netflix |
Check out Historical Fundamental Analysis of Aerovate Therapeutics to cross-verify your projections. For information on how to trade Aerovate Stock refer to our How to Trade Aerovate Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aerovate Therapeutics. If investors know Aerovate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aerovate Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.13) | Return On Assets (0.44) | Return On Equity (0.74) |
The market value of Aerovate Therapeutics is measured differently than its book value, which is the value of Aerovate that is recorded on the company's balance sheet. Investors also form their own opinion of Aerovate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aerovate Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aerovate Therapeutics' market value can be influenced by many factors that don't directly affect Aerovate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aerovate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aerovate Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aerovate Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.